Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Is she saying that TLT can get fund rather than PP in 2024?

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Mar 30, 2024 12:27pm

198 Views

Post# 35961084

RE:RE:RE:RE:RE:RE:RE:Is she saying that TLT can get fund rather than PP in 2024?

Eoga, Yes. I think so. They need to right size the debt so that they have a nice runway to get past BTD and any partner/regional deals they are negotiating. Would also be nice if they get enough to complete the GLP for solid tumors. This debt will add to cash burn but if they get enough to last a cpl/few years??? IMO And it 'should' take the lid off this stock price.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions